Navigation Links
Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
Date:11/5/2013

SAN DIEGO, Nov. 5, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) announced today that it has entered into an antibody and vaccine development collaboration with The Scripps Research Institute (TSRI) of La Jolla, CA. Under the terms of the agreement, Sorrento obtains an exclusive, worldwide license to TSRI's novel technologies based on ghrelin signaling inhibition for the prevention and treatment of obesity and other metabolic disorders.

A research group at TSRI, led by Dr. Kim Janda, has pioneered innovative technology to combat obesity exploiting antibody-mediated neutralization of ghrelin, a hunger-stimulating peptide hormone and an integral component of the food intake regulation circuit. Dr. Janda's group has demonstrated statistically significant effects, such as reduced food intake and body weight loss, in rodents. The scientific articles detailing these studies were published in the Proceedings of the National Academy of Sciences (PNAS)1,2 and Molecular Pharmaceutics3. The ghrelin peptide analogs described by the TSRI team represent a unique opportunity for Sorrento to utilize its proprietary G-MAB® antibody library technology to identify fully human antibodies for the sequestration of ghrelin-mediated appetite process. Sorrento intends to develop vaccines and antibody-based therapeutics to fight obesity.

"Our colleagues at TSRI have presented promising animal data and we are pleased to collaborate on the development of human vaccines and fully human antibody therapeutics to help address this important public health issue. This discovery program represents a novel approach to combating obesity," said Dr.

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Awarded Third Phase I STTR Grant
2. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
6. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
7. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
8. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
9. Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
10. Sorrento Therapeutics to Present at Two Healthcare Conferences
11. Sorrento Therapeutics Completes IgDraSol Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
(Date:4/21/2014)... consider ways to ease prohibitions on marijuana, the public ... the past century may provide valuable lessons, according to ... legalized marijuana in Colorado and Washington for recreational uses ... to best allow the production, sales and the use ... social ills. , A new study published online by ...
(Date:4/20/2014)... type of cell in the lining of the bladder ... according to researchers at the Stanford University School of ... first to pinpoint the normal cell type that can ... first to show that most bladder cancers and their ... explains why many human bladder cancers recur after therapy. ...
(Date:4/18/2014)... University School of Medicine researchers have been awarded two-year ... Novo Nordisk announced this month. Of the 110 initial ... Biologics Science Forum Program, only four projects were funded, ... They are Jonathan Powell, M.D., Ph.D.; G. William Wong, ... Powell, a professor of oncology, will use his $500,000 ...
(Date:4/18/2014)... available in French . ... practice and regenerative medicine. A team led by Ludwik ... Paris Tech) and Didier Letourneur from the Laboratoire Recherche ... just demonstrated that the principle of adhesion by aqueous ... repair soft-tissue organs and tissues. This easy-to-use gluing method ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
Breaking Medicine News(10 mins):Health News:Regulating legal marijuana could be guided by lessons from alcohol and tobacco, study says 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2
... Free Support Magazine Helps Individuals and Families Embrace Life to ... N.J., Dec. 5 ConvaTec, a world-leading developer and marketer ... today the launch of ConTact, the new global lifestyle magazine ... with practical advice and feature articles on living a healthy ...
... 5 Empire BlueCross BlueShield today,announced that its employees ... 2008 Associate Giving Campaign. This amount is the,result ... match from the,WellPoint Foundation, Inc. , ... and health services,organizations are especially in need of help," ...
... Call on BCBS and OPM to Restore 2008 Benefits, Extend "Open Season" ... , Affected Patients and Doctors Available to ... , WASHINGTON, Dec. 5 Tick, Tick, Tick! Nearly half ... 8th to either change health care plans or face some costly penalties ...
... SEYMOUR, Tenn., Dec. 5 For many, city ... The usual hustle and bustle is further,glamorized by ... crowds,eager to soak in the joyful atmosphere. However, ... can be an emotionally trying time,filled with expectations ...
... N.J., Dec. 5 World Gourmet Marketing, LLC, creator,of the ... healthier,snack alternatives at the concession stands of the IZOD CENTER. ... when obesity is a national concern, the Nets are recognizing ... offerings,include: World Gourmet,s Sensible Portions Multi Grain Crisps, which are,baked, ...
... 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life ... laboratory services, announced today that the Company will release ... on December 17, 2008, at approximately 5:00 p.m. (ET). ... which will be held on December 18, 2008, at ...
Cached Medicine News:Health News:ConvaTec Launches New Lifestyle Magazine for People With an Ostomy 2Health News:Empire BlueCross BlueShield Associates Commit Over $1 Million to Community Organizations in 2008 2Health News:Clock Ticking for Millions of Federal Employees Hoping to Avoid Blue Cross/Blue Shield Benefits Cut 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 3Health News:Nets Provide Fans with Healthy In-Game Snack Option 2Health News:DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast 2
Hydrophilic Acrylic Intraocular Lens, AC depth: 4.65....
The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
... The Bausch & Lomb SoFlex™ ... Lenses are intended to be ... the visual correction of aphakia ... age or older where a ...
Liberty Three Piece PMMA Lens with UV Absorber....
Medicine Products: